UNC Lineberger News

DeSimone elected to all three branches of the National Academies

DeSimone elected to all three branches of the National Academies

Dr. Joseph DeSimone, Chancellor’s Eminent Professor of Chemistry at the University of North Carolina at Chapel Hill and UNC Lineberger member, has been elected to the Institute of Medicine, one of the highest honors in the fields of health and medicine a U. S. scientist can receive.

DeSimone elected to all three branches of the National Academies - Read More…

Having dependent children motivates advanced cancer patients to pursue more aggressive care

A pilot study of people with advanced cancer indicates that parental status is an important factor in treatment decision-making, with the majority stating that being a parent motivates them to pursue life-extending treatments, according to research presented this week at ASCO’s 2014 Quality Care Symposium by Devon Check, a Ph.D. student at the University of North Carolina at Chapel Hill.

Having dependent children motivates advanced cancer patients to pursue more aggressive care - Read More…

New Template for Survivorship Care Plans Released

New Template for Survivorship Care Plans Released

Deborah K. Mayer, PhD, RN, professor in the UNC School of Nursing and director of cancer survivorship at UNC Lineberger, leads national efforts to address growing need for post-treatment planning for cancer patients.

New Template for Survivorship Care Plans Released - Read More…

Endeavors: Just Add Liver

Endeavors: Just Add Liver

A tale of viruses, stem cells, and global health

Endeavors: Just Add Liver - Read More…

Inaugural She ROCKS luncheon raises funds for ovarian cancer

Inaugural She ROCKS luncheon raises funds for ovarian cancer

The first annual She ROCKS (Research, Ovarian, Cancer, Knowledge, Support) event held recently in Wilmington raised funds that will go directly towards ovarian cancer research based at UNC Lineberger Comprehensive Cancer Center.

Inaugural She ROCKS luncheon raises funds for ovarian cancer - Read More…

All the Cell’s a Stage

All the Cell’s a Stage

Brian Strahl, PhD, and his band of biochemists unravel the complicated mysteries of the epigenetic code to find a culprit in cancer development.

All the Cell’s a Stage - Read More…

New website launched to help women learn about risk factors for breast cancer

New website launched to help women learn about risk factors for breast cancer

The UNC Breast Cancer and the Environment Research Program (BCERP) has announced the official launch of myBCrisk.org, an interactive website designed to increase knowledge about breast cancer risk factors, especially among young African-American women.

New website launched to help women learn about risk factors for breast cancer - Read More…

Coach Hatchell inspires as featured speaker at 10th Annual Roy Williams' Fast Break Against Cancer

Coach Hatchell inspires as featured speaker at 10th Annual Roy Williams' Fast Break Against Cancer

Now in its 10th year, this annual event hosted by Coach Roy Williams raised $213,000 for cancer research and treatment at UNC Lineberger Comprehensive Cancer Center.

Coach Hatchell inspires as featured speaker at 10th Annual Roy Williams' Fast Break Against Cancer - Read More…

Milowsky appointed medical director of the N.C. Cancer Hospital

Milowsky appointed medical director of the N.C. Cancer Hospital

CHAPEL HILL, NC – Matthew Milowsky, MD, associate professor and co-director of the Urologic Oncology Program at UNC Lineberger Comprehensive Cancer Center, has been appointed as the clinic medical director of the N.C. Cancer Hospital.

Milowsky appointed medical director of the N.C. Cancer Hospital - Read More…

Komen awards more than $875,000 to UNC Lineberger researchers

Komen awards more than $875,000 to UNC Lineberger researchers

Susan G. Komen® has awarded over $875,000 in research funding to UNC Lineberger Comprehensive Cancer Center.

Komen awards more than $875,000 to UNC Lineberger researchers - Read More…

Team UNC Oncology among top fundraising teams for Light The Night Walk

Team UNC Oncology among top fundraising teams for Light The Night Walk

The Leukemia & Lymphoma Society (LLS) held their Light The Night Walk at Rock Quarry Park in Durham on Saturday, September 20. The evening fundraising walk celebrated and commemorated lives touched by blood cancer. More than a walk, the evening had a carnival atmosphere and included refreshments, entertainment, music and kids' activities

Team UNC Oncology among top fundraising teams for Light The Night Walk - Read More…

UNC Lineberger hosts Metastatic Breast Cancer Network Conference

UNC Lineberger hosts Metastatic Breast Cancer Network Conference

The Metastatic Breast Cancer Network (MBCN) held its 8th Annual National Conference in Chapel Hill September 19-21, 2014 in conjunction with the UNC Lineberger Comprehensive Cancer Center.

UNC Lineberger hosts Metastatic Breast Cancer Network Conference - Read More…

Nielsen named Director of UNC Urologic Oncology

Nielsen named Director of UNC Urologic Oncology

Matthew Nielsen, MD, MS, assistant professor of urology and adjunct assistant professor of epidemiology and health policy & management, has been named director of urologic oncology in the UNC Department of Urology. In his new role, he joins Matthew Milowsky, MD, associate professor of medicine, as co-director of the Multidisciplinary Genitourinary Oncology Service at the N.C. Cancer Hospital.

Nielsen named Director of UNC Urologic Oncology - Read More…

Sharon Campbell honored at the 2014 Hyman L. Battle Distinguished Cancer Research Award reception

Sharon Campbell honored at the 2014 Hyman L. Battle Distinguished Cancer Research Award reception

On September 24, 2014, UNC Lineberger held a reception to honor Dr. Sharon Campbell, recipient of the 2014 Hyman L. Battle Distinguished Cancer Research Award.

Sharon Campbell honored at the 2014 Hyman L. Battle Distinguished Cancer Research Award reception - Read More…

The Geneticist

The Geneticist

With his selection to the NIH Council of Councils, Terry Magnuson, PhD, becomes the first UNC scientist appointed to the board dedicated to funding the biggest ideas in medical research.

The Geneticist - Read More…

UNC researchers find final pieces to the circadian clock puzzle

UNC researchers find final pieces to the circadian clock puzzle

Sixteen years after scientists found the genes that control the circadian clock in all cells, the lab of UNC’s Aziz Sancar, MD, PhD, discovered the mechanisms responsible for keeping the clock in sync.

UNC researchers find final pieces to the circadian clock puzzle - Read More…

Damania appointed Assistant Dean for Research

Damania appointed Assistant Dean for Research

Blossom Damania, PhD, professor of microbiology and immunology, has been named Assistant Dean for Research at the UNC School of Medicine, effective immediately.

Damania appointed Assistant Dean for Research - Read More…

Basch contributes to new ASCO guidelines for prostate cancer treatment

Basch contributes to new ASCO guidelines for prostate cancer treatment

New clinical guidelines have been announced for the treatment of men with metastatic castration-resistant prostate cancer (CRPC) by the American Society of Clinical Oncology (ASCO) and Cancer Care Ontario (CCO). Ethan Basch, MD, director of the Cancer Outcomes Research Program at UNC Lineberger Comprehensive Cancer Center, served as the co-chair of the ASCO/CCO expert panel that developed the guideline.

Basch contributes to new ASCO guidelines for prostate cancer treatment - Read More…

UNC researchers find new genetic target for a different kind of cancer drug

UNC researchers find new genetic target for a different kind of cancer drug

Upstream of the proteins that cancer cells use to proliferate sits RBM4, a gene-splicing protein that UNC researcher Zefeng Wang, PhD, discovered is drastically reduced in human lung and breast cancer cells.

UNC researchers find new genetic target for a different kind of cancer drug - Read More…

Popular cancer drug target implicated in cardiovascular defects

Popular cancer drug target implicated in cardiovascular defects

Research led by UNC’s Kathleen Caron, PhD, shows that halting the protein CXCR7 leads to over activation of adrenomedullin, a hormone needed at proper levels for normal cardiovascular development

Popular cancer drug target implicated in cardiovascular defects - Read More…

Changing the face of clinical trials

Changing the face of clinical trials

UNC Lineberger secures three major NCI grants to advance the nation’s clinical trials program.

Changing the face of clinical trials - Read More…

Anders presents at 13th Annual Round Asia Oncology Forum

Anders presents at 13th Annual Round Asia Oncology Forum

Carey Anders, MD, UNC Lineberger member and associate professor, was a presenter and moderator at The 13th Annual Round Asia Oncology Forum (RAOF) in Hong Kong on August 29 - 30, 2014. The theme of this year’s forum was “Expanding our armory in personalized cancer treatment.”

Anders presents at 13th Annual Round Asia Oncology Forum - Read More…

Eshelman gives $3 million gift to Center for Integrative Chemical Biology and Drug Discovery

Eshelman gives $3 million gift to Center for Integrative Chemical Biology and Drug Discovery

The UNC Eshelman School of Pharmacy has received a $3 million gift from philanthropist and pharmaceutical-industry executive Fred Eshelman. Eshelman’s gift will support the work of the School’s Center for Integrative Chemical Biology and Drug Discovery, led by UNC Lineberger member Stephen Frye, PhD. The center is dedicated to evaluating and developing potential drug targets discovered by UNC faculty.

Eshelman gives $3 million gift to Center for Integrative Chemical Biology and Drug Discovery - Read More…

2014 University Cancer Research Fund Innovation Awards announced

Six researchers have been awarded 2014 University Cancer Research Fund (UCRF) Innovation Awards for promoting innovative and new ideas in cancer research at the University of North Carolina at Chapel Hill.

2014 University Cancer Research Fund Innovation Awards announced - Read More…